Sponsor

Guangzhou Women and Children's Medical Center

Clinical research sponsor

Published trials13

Recruiting shown5

Roles2

SourceClinicalTrials.gov

Clinical trials

13 shown

Human Genes and Microbiota in Early LifeNCT06926166 · lead sponsor · 2019-04-01

RECRUITING

Maternal Grandmothers in the Born in Guangzhou Cohort StudyNCT03633162 · lead sponsor · 2018-05-21

RECRUITING

GDM and Its Consequences in Mothers and OffspringsNCT04529889 · lead sponsor · 2012-02-01

RECRUITING

Twins Born in GuangzhouNCT03331133 · lead sponsor · 2012-02-01

RECRUITING

The Born in Guangzhou Cohort Study (BIGCS)NCT02526901 · lead sponsor · 2012-02-01

RECRUITING

Impact of Robotic Versus Endoscopic Surgery on Nipple Nerve Function Following Nipple-Sparing Mastectomy for Breast CancerNCT07850154 · lead sponsor · 2026-10-01

NOT_YET_RECRUITING

Safety and Effectiveness of Robotic-Assisted Remote Surgery for Breast TumorsNCT07850323 · lead sponsor · 2026-08-01

COMPLETED

A Study Evaluating the Efficacy and Safety of De Trastuzumab (T-DXd) in Combination with Immunotherapy for the Neoadjuvant Treatment of HR-positive HER2 Low-expressing Chinese Patients with Early-stage Breast CancerNCT06733233 · lead sponsor · 2025-01-01

NOT_YET_RECRUITING

Robotic-Assisted vs. Endoscopic-Assisted Sentinel Lymph Node Biopsy in Breast CancerNCT07741734 · lead sponsor · 2021-10-01

ACTIVE_NOT_RECRUITING

Robotic-Assisted Versus Endoscopic-Assisted Axillary Lymph Node Dissection in Breast CancerNCT07693361 · lead sponsor · 2021-10-01

ACTIVE_NOT_RECRUITING

Guangzhou Women's Health Cohort Study (GWHCS)NCT05506800 · lead sponsor · 2016-03-03

SUSPENDED

Kindergarten-based Intervention for Childhood Obesity in Guangzhou(KICOG)NCT03022474 · lead sponsor · 2012-01-01

COMPLETED

Contrast The Role of Avitene And OK-432 in Reducing Seroma Formation After Axillary Lymphadenectomy for Breast CancerNCT02158299 · collaborator · 2013-10-01

UNKNOWN

Sponsor roles

lead sponsor12

collaborator1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.